Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles
- 16 March 2017
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 23 (3) , 218-224
Abstract
Diseases affecting the posterior segment of the eye are the most common cause of visual disorders in industrialized countries. This scenario has encouraged the development of new treatment modalities for these diseases, such as drug loaded implants with prolonged drug release. The aim of the present work was to create a polymeric based biodegradable ophthalmic implant for the delivery of dexamethasone. For this purpose, we prepared and compared the in vitro release profiles of dexamethasone ophthalmic implants produced by two methods: melting casting and solvent casting. The type of the biodegradable polymer used - poly (ɛ-caprolactone) (PCL) and poly(lactic acid) (PLA); the drug loading (10% and 25%, w/w), the molecular weight of PCL (37 kDa and 14 kDa) and the form of the drug (dexamethasone and dexamethasone disodium phosphate) were also investigated. The results show that the preparation method has little influence on the obtained release profiles, being the type of polymer the most significant factor affecting the release profiles; nonetheless, a better distribution of dexamethasone was obtained for the devices prepared by melting casting.Keywords
This publication has 20 references indexed in Scilit:
- Pharmacokinetics of a Sustained-Release Dexamethasone Intravitreal Implant in Vitrectomized and Nonvitrectomized EyesInvestigative Ophthalmology & Visual Science, 2011
- DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTSRetina, 2011
- Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal ImplantInvestigative Ophthalmology & Visual Science, 2011
- Toward a Better Understanding of Human Eye Disease2011
- New Developments in Corticosteroid Therapy for UveitisOphthalmologica, 2010
- Ocular Drug DeliveryThe AAPS Journal, 2010
- Proliferative retinopathies: Angiogenesis that blindsThe International Journal of Biochemistry & Cell Biology, 2010
- Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age‐related macular degeneration: a review of current practiceClinical and Experimental Optometry, 2008
- Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical ConsiderationsToxicologic Pathology, 2008
- Sistemas de transporte de drogas para o segmento posterior do olho: bases fundamentais e aplicaçõesArquivos Brasileiros de Oftalmologia, 2007